Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
07/2010
07/07/2010CN101768097A Method for preparing selenic acid arginine and application of selenic acid arginine
07/07/2010CN101768086A Amino methanol derivant and salt compound thereof as well as synthesizing method and medical application thereof
07/07/2010CN101766768A Traditional Chinese medicine granule for treating allergic rhinitis
07/07/2010CN101766719A Chinese herbal preparation for allergic rhinitis treatment
07/07/2010CN101766713A Anti-allergic traditional Chinese medicine preparation and preparation method thereof
07/07/2010CN101766682A Process for extracting and purifying total alkaloids of Sophora alopecuroides
07/07/2010CN101766680A Comprehensive extraction method of glycyrrhiza
07/07/2010CN101766665A External liniment for treating infantile eczema
07/07/2010CN101766662A Process for efficiently concentrating cordycepin
07/07/2010CN101766657A Compound for activating immune cell and preparation method thereof
07/07/2010CN101766656A Combination containing mushroom polysaccharide and preparation method thereof
07/07/2010CN101766652A Propolis donkey-hide geltin
07/07/2010CN101766647A Purpose of montmorillonite in treating allergic rhinitis and skin allergy
07/07/2010CN101766640A Preparation for panaxoside-Rd aqueous solution of propylene glycol and new application thereof in inflammation resistance, immune suppression and organ transplant rejection resistance
07/07/2010CN101766639A Applying liquid for treating miliaria
07/07/2010CN101766617A Compound composition of intal and Statins
07/07/2010CN101766299A Immune regulation composite
07/07/2010CN101766228A Iimmune stimulatory infant nutrition
07/07/2010CN101032532B Medicine composition including active substrates extracted from Sang Huang, the preparing method and the application in the producing of medicine thereof
07/06/2010US7749960 An enteral composition or a pharmaceutical containing osteoprotegerin obtained from human or bovine milk or colostrum; preventing or treating disorders associated with bone metabolism and immune function
07/06/2010US7749753 modulation of transport proteins in biological cells; genetic engineering; antibodies
07/06/2010US7749752 Using vector comprisng nucleotide sequences coding cell binding elements to transform cells and identify lymphocyte response modulators
07/06/2010US7749745 Herpes simplex virus comprising a mutation within the BstEII-EcoNI fragment of the BamHI x fragment of said virus; cancer vaccine
07/06/2010US7749735 Interferon receptor variant for treatment and prevention of cell proliferative, autoimmune and viral diseases; prolonged activation of interferon beta
07/06/2010US7749719 bioassay to detect diagnosis of skin cancer; isolated host cell transfected with the recombinant expression vector encoding an immunogenic protein; immunogen or vaccine for cancer prevention and treatment; immunotherapy
07/06/2010US7749718 Method for raising or isolating an antibody to DCRS5
07/06/2010US7749495 Method for inducing an anti-tumor and anti-cachexia immune response in mammals
07/06/2010US7749493 Chimeric adenoviruses
07/06/2010US7748379 Methods and apparatus for relieving headaches, rhinitis and other common ailments
07/06/2010CA2446149C Vitamin d analogues
07/06/2010CA2437109C Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity
07/06/2010CA2393883C Salicylamide derivatives
07/06/2010CA2370814C Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit
07/06/2010CA2333188C Multiparticulate pharmaceutical form with programmed and timed release and preparation method
07/06/2010CA2328056C Attenuated mutants of salmonella which constitutively express the vi antigen
07/06/2010CA2295572C Treatment of inflammatory disorders of the bowel and urinary bladder
07/06/2010CA2209360C Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen
07/06/2010CA2123049C Pharmaceutical containing the p40 subunit of interleukin 12
07/01/2010WO2010075558A2 Compositions and methods for inhibition of the jak pathway
07/01/2010WO2010075270A1 4, 6-disubstituted 2-amino-pyrimidines as histamine h4 receptor modulators
07/01/2010WO2010075263A2 Compounds and methods for enhancing erythropoiesis
07/01/2010WO2010075239A1 Dosage regimen for a s1p receptor agonist
07/01/2010WO2010075067A2 Methods for diagnosing and treating autoimmune disorders
07/01/2010WO2010074284A1 Pyrazolopyrimidine compound
07/01/2010WO2010074266A1 Anti-cd4 antibody
07/01/2010WO2010074244A1 Isoquinoline derivative
07/01/2010WO2010074218A1 Anti-human midkine antibody
07/01/2010WO2010074126A1 Recombinant avian-infectious coryza vaccine and method for producing same
07/01/2010WO2010073719A1 Eg5 inhibitor
07/01/2010WO2010073642A1 Bioactive agent, pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent
07/01/2010WO2010072823A1 PYRAZOLE[1,5a]PYRIDINE DERIVATIVES
07/01/2010WO2010072797A1 Compounds and methods for the treatment of autoimmune and inflammatory disease
07/01/2010WO2010072712A1 Biaryl benzylamine derivatives
07/01/2010WO2010072703A1 Dosage regimen of an s1p receptor agonist
07/01/2010WO2010054024A3 1, 2 -thiazol yl derivatives as cannabinoid receptor ligands
07/01/2010WO2010039563A3 Protective vaccine against staphylococcus aureus biofilms comprising cell wall-associated immunogens
07/01/2010WO2010024956A3 Antihistamine and antihistamine-like nasal application, products, and method
07/01/2010US20100168244 Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
07/01/2010US20100168227 Preventative Treatment and Remission of Allergic Diseases
07/01/2010US20100168199 Kinase Inhibitors
07/01/2010US20100168187 Therapeutic combination
07/01/2010US20100168166 Method of Providing An Antihistaminic Effect in a Hepatically Impaired Patient
07/01/2010US20100168165 Method of treating disease involving myelin and/or axonal loss
07/01/2010US20100168159 Hetero compound
07/01/2010US20100168158 Modulators of cystic fibrosis transmembrane conductance regulator
07/01/2010US20100168144 Inhibitors of protein kinases
07/01/2010US20100168139 Inhibitors of human phosphatidylinositol 3-kinase delta
07/01/2010US20100168116 3,6-substituted imidazol[1,2-b]pyridazine analogs for treating allergic and inflammatory diseases
07/01/2010US20100168107 Imidazole compounds for the treatment of neurodegenerative disorders
07/01/2010US20100168085 Dopamine and agonists and antagonists thereof for modulation of suppressive activity of CD4+CD25+ regulatory T cells
07/01/2010US20100168079 Biaryl Benzylamine Derivatives
07/01/2010US20100168077 Novel Pyridine Derivatives, Processes for Preparing Them, Pharmaceutical Compositions Thereof
07/01/2010US20100168076 Diphenyl substituted alkanes
07/01/2010US20100168062 Quinoxaline Derivatives as Tyrosine Kinase Activity Inhibitors
07/01/2010US20100168054 Functionalized Beta 1,6 Glucosamine Disaccharides and Process for Their Preparation
07/01/2010US20100168053 Oral delivery system for methylcobalamin to treat disorders
07/01/2010US20100168047 Inhibition of apoptosis-specific eIF-5A ("eIF-5A1") with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics
07/01/2010US20100168032 Smart Pro-Drugs of Serine Protease Inhibitors
07/01/2010US20100168031 Lat peptides and their use in assays for identifying immunosuppressants
07/01/2010US20100168005 Pyridin-3-yl derivatives as immunomodulating agents
07/01/2010US20100167980 Prolyl Endopeptidase Inhibitors For Reducing or Preventing Neutrophilic Inflammation
07/01/2010US20100167393 Modified human thymic stromal lymphopoietin
07/01/2010US20100166862 Local Complement Inhibition for Treatment of Complement-Mediated Disorders
07/01/2010US20100166840 Liposome having lipid membrane containing bacterial cell component
07/01/2010US20100166802 Methods and reagents for decreasing clinical reaction to allergy
07/01/2010US20100166797 Gammaretrovirus associated with cancer
07/01/2010US20100166793 Protease-resistant modified seb and vaccine containing the same
07/01/2010US20100166789 Proteins for use in diagnosing and treating infection and disease
07/01/2010US20100166788 Immunogens from uropathogenic escherichia coli
07/01/2010US20100166787 Vaccines and methods for using the same
07/01/2010US20100166778 Toll-Like Receptor 3 Antagonists
07/01/2010US20100166774 Stable Protein Formulations
07/01/2010US20100166766 Engineered anti-tslp antibody
07/01/2010US20100166763 Method for determining the immunogenicity of an antigen
07/01/2010US20100166761 Compositions and methods for the treatment of immune related diseases
07/01/2010US20100166753 Humanized monoclonal antibodies that protect against shiga toxin induced disease
07/01/2010US20100166736 Immunostimulatory oligonucleotide multimers
07/01/2010US20100166733 Mcp-1 splice variants and methods of using same
07/01/2010US20100166732 Small streptococcus pyogenes antigens and their use
07/01/2010US20100166705 Culturing circular ssDNA viruses for the production of vaccines
1 ... 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 ... 1172